|
SDAD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.3289003231165E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.38760000659255E-09 |
| Normal-vs-Stage2 |
7.55310000000176E-05 |
| Normal-vs-Stage3 |
1.44930000001153E-07 |
| Normal-vs-Stage4 |
1.72390000052758E-08 |
| Stage1-vs-Stage2 |
9.587600E-01 |
| Stage1-vs-Stage3 |
6.257600E-01 |
| Stage1-vs-Stage4 |
1.602620E-01 |
| Stage2-vs-Stage3 |
7.964800E-01 |
| Stage2-vs-Stage4 |
4.207400E-01 |
| Stage3-vs-Stage4 |
4.607000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.85950049697215E-10 |
| Normal-vs-AfricanAmerican |
2.554500E-04 |
| Normal-vs-Asian |
2.07389999999918E-05 |
| Caucasian-vs-AfricanAmerican |
9.352000E-01 |
| Caucasian-vs-Asian |
7.937600E-01 |
| AfricanAmerican-vs-Asian |
7.982200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.09140000370544E-08 |
| Normal-vs-Female |
7.0777994576332E-10 |
| Male-vs-Female |
4.641600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.383500003449E-08 |
| Normal-vs-Age(41-60Yrs) |
5.20389997760162E-09 |
| Normal-vs-Age(61-80Yrs) |
3.0137000006647E-08 |
| Normal-vs-Age(81-100Yrs) |
8.444100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.644800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.622000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.412600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.894800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.665200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.449000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.000200E-01 |
| Classical-VS-Follicular |
7.062400E-02 |
| Classical-VS-Other |
2.706800E-01 |
| Classical-VS-Normal |
2.16310000000774E-06 |
| Tall-VS-Follicular |
5.147000E-01 |
| Tall-VS-Other |
4.649400E-01 |
| Tall-VS-Normal |
2.046000E-04 |
| Follicular-VS-Other |
7.403800E-01 |
| Follicular-VS-Normal |
1.08810000010173E-07 |
| Other-VS-Normal |
7.495000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.2806000038168E-08 |
| Normal-vs-N1 |
2.0964999958295E-08 |
| N0-vs-N1 |
1.513770E-01 |
|
|
